| Background strain: | cMJ030 | Click here to order this strain from the Chlamydomonas Resource Center. The background strain comes free with every order. |
| Transformation condition: | RY0402 | |
| Antibiotic resistance: | resistant to paromomycin |
Insertion junctions | |||||
| Insertion junction | Locus systematic id | Locus common name | Defline | Feature | Confidence (%) |
|---|---|---|---|---|---|
| LMJ.RY0402.046759_1 | Cre16.g682950 | RAD9 | DNA damage checkpoint protein; (1 of 1) K10994 - cell cycle checkpoint control protein RAD9A [EC:3.1.11.2] (RAD9A) | intron | 73 |
If you use this mutant for your work, please cite: Li et al. 2019 Nature Genetics.
This mutant exhibited a phenotype under the following conditions:
| Cisplatin, screen 1 of 4 (No growth detected) |
| Cisplatin, screen 2 of 4 (~60.0% growth defect) |
| Cisplatin, screen 3 of 4 (No growth detected) |
| Cisplatin, screen 4 of 4 (~90.0% growth defect) |
| Mannitol, screen 1 of 1 (~50.0% growth defect) |
| Methyl methanesulfonate, screen 3 of 4 (~90.0% growth defect) |
| Methyl methanesulfonate, screen 4 of 4 (~90.0% growth defect) |
| Mitomycin C, screen 2 of 4 (~50.0% growth defect) |
| Mitomycin C, screen 3 of 4 (~50.0% growth defect) |
| Mitomycin C, screen 4 of 4 (~50.0% growth defect) |
| Zeocin, screen 3 of 5 (~40.0% growth defect) |
| Zeocin, screen 4 of 5 (~40.0% growth defect) |
| Zeocin, screen 5 of 5 (~30.0% growth defect) |
Note: Not all phenotypes can be confidently associated with a specific gene or insertion; phenotypes can be caused by unmapped second-site mutations. Please see the gene pages for statistically significant gene-phenotype links. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.